Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine effects on myocardial perfusion in chronic stable angina
RBR-5fysqrhPhase 4Completed
- Sponsor
- Medicina Nuclear do Alto da XV
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ivabradine in angina pectoris, sponsored by Medicina Nuclear do Alto da XV. Primary endpoint: Total perfusion defect on stress SPECT. Started Nov 2019; status: completed.
02
Drugs
ivabradine
03
Conditions
angina pectoris
Beyond the preview
Go deeper on RBR-5fysqrh.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5fysqrh.